- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01632501
Safety and Efficacy of the Percutaneous Intervention Performed With Devices of a Single-brand (Tsunami)
July 2, 2012 updated by: Denise Oliveira, Hospital Sao Lucas da PUCRS
The freedom of choice in medicine is based on the physician's ability to treat their patients with the best available therapy.
The armamentarium for percutaneous intervention is frequently determined on the basis of subjective criteria and the experience of the interventional cardiologist.
The evaluation of devices used in coronary intervention, especially angiography and its clinical outcomes, has rarely been investigated; the exceptions are studies on stents.
Therefore, the freedom of choice for the interventional cardiologist has been challenged, especially because of cost restrictions.
This way this study aims to assess the safety and efficacy of a device of a single brand in performing percutaneous transluminal coronary angioplasty (guide catheters, guidewires, balloons, and stents) in selected patients.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
84
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
The study included both male and female patients for stent implantation referred for angioplasty of coronary arteries with more than 18 years.
Exclusion Criteria:
- chronic total occlusion angioplasty,
- saphenous graft angioplasty,
- bifurcation angioplasty (lateral branch greater than 1.5 mm)
- plans to perform angioplasty on more than one vessel during the same procedure
- and primary angioplasty in acute myocardial infarction
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Occurrence of: need to change the materials during the procedure (angioplasty).
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (Actual)
March 1, 2012
Study Registration Dates
First Submitted
June 26, 2012
First Submitted That Met QC Criteria
June 28, 2012
First Posted (Estimate)
July 3, 2012
Study Record Updates
Last Update Posted (Estimate)
July 4, 2012
Last Update Submitted That Met QC Criteria
July 2, 2012
Last Verified
January 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PCR1TS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Heart Disease
-
Peking University Third HospitalCompletedCoronary Microvascular Dysfunction | Obstructive Coronary Heart DiseaseChina
-
Shenyang Northern HospitalNot yet recruitingCoronary Heart Disease (CHD)China
-
Johns Hopkins UniversityCanon Medical Systems, USARecruiting
-
MedImmune LLCCompletedStable Coronary Heart DiseaseUnited States
-
Medical University of LodzBaxter Healthcare CorporationUnknownCHD - Coronary Heart DiseasePoland
-
University of ZurichCompletedStable Coronary Heart DiseaseSwitzerland
-
Hamad Medical CorporationMayo ClinicCompleted
-
Centro de estudios en Cardiologia IntervencionistaCompletedCoronary Heart Disease | Coronary RestenosisArgentina
-
Deutsches Herzzentrum MuenchenCompletedCoronary Heart DiseaseGermany
-
Henan Institute of Cardiovascular EpidemiologyNot yet recruitingStable Coronary Heart Disease
Clinical Trials on Coronary stent - Tsunami
-
Medinol Ltd.CompletedIschemic Heart DiseaseIsrael, Sweden, Belgium, Germany
-
Odense University HospitalCompletedIschemic Heart Disease | Percutaneous Coronary Intervention | Coronary AtherosclerosisDenmark
-
Abbott Medical DevicesCompleted
-
A.O. Ospedale Papa Giovanni XXIIIMedtronic; Case Western Reserve UniversityCompletedAcute Myocardial InfarctionItaly
-
Palmaz ScientificClinLogix. LLCCompleted
-
CCRF Consulting Co., Ltd.Peking University First Hospital; Terumo Medical(shanghai) Co.,Ltd.UnknownFree Rate of Cardiac or Cerebrovascular Events | Transradial-transfemoral Coronary Interventions ComparisonChina
-
BioSync Scientific Pvt. Ltd.Cardialysis BV; MIV Therapeutics Inc.UnknownCoronary Artery Disease
-
Rigshospitalet, DenmarkCompleted
-
NHS National Waiting Times Centre BoardCompletedStent Thrombosis | Coronary Stent Occlusion | Coronary Artery PerforationUnited Kingdom
-
OrbusNeichCompletedCoronary Artery Disease | Coronary Artery StenosisNetherlands, Belgium, United Kingdom, France, Germany, Austria